Daxor Corporation has introduced its ezBVA Lab diagnostic service for outpatient blood volume analysis at a healthcare facility in eastern Kansas. This service offers clinicians precise, 98% accurate blood volume measurements within 24 hours without the need for capital equipment or lab infrastructure. By providing objective data on blood, plasma, and red cell volume, the service helps optimize patient treatment, reduce hospital readmissions, and lower healthcare costs. This expansion strengthens Daxor's presence in the Midwest and supports value-based care improvements.
BioMarin Pharmaceutical Inc. saw its stock gain momentum after Jefferies raised its price target to $105, signaling strong confidence in the biotech firm. The company secured new revenue streams through a patent settlement with Ascendis Pharma, earni...
Zoomd Technologies Ltd. reported a second-quarter EPS of $0.01, surpassing analyst estimates of $0.0038, signaling better-than-expected profitability. Although quarterly revenue was $7.67 million, slightly below the $8.41 million forecast, the compan...
Snowflake's stock surged following a price target increase to $405 by Cantor Fitzgerald analyst Thomas Blakey, signaling a 24.21% upside. Analysts expect strong Q2 results with earnings of $0.45 per share and revenues of $1.47 billion, reflecting nea...
Tesla has announced a significant increase in its 2026 capital budget to $25 billion, with a major portion allocated to expanding production of its Optimus robots. This move highlights Tesla's commitment to advancing robotics technology alongside its...
Burlington Stores' stock fell 7.6% after reporting Q2 earnings with adjusted EPS of $2.37 beating estimates, but revenue of $3.002 billion slightly missed expectations. The company showed 11% revenue growth and a 46.2% gross margin, marking its 15th ...
